The gut-microbiota-brain axis in autism: what Drosophila models can offer?

The idea that alterations in gut-microbiome-brain axis (GUMBA)-mediated communication play a crucial role in human brain disorders like autism remains a topic of intensive research in various labs. Gastrointestinal issues are a common comorbidity in patients with autism spectrum disorder (ASD). Although gut microbiome and microbial metabolites have been implicated in the etiology of ASD, the underlying molecular mechanism remains largely unknown. In this review, we have summarized recent findings in human and animal models highlighting the role of the gut-brain axis in ASD. We have discussed genetic and neurobehavioral characteristics of Drosophila as an animal model to study the role of GUMBA in ASD. The utility of Drosophila fruit flies as an amenable genetic tool, combined with axenic and gnotobiotic approaches, and availability of transgenic flies may reveal mechanistic insight into gut-microbiota-brain interactions and the impact of its alteration on behaviors relevant to neurological disorders like ASD.

Automated summary

The role of alterations in the gut-microbiome-brain axis (GUMBA) in human brain disorders like autism is a topic of intensive research, with gastrointestinal issues being a common comorbidity in ASD patients. Recent findings in both human and animal models, particularly using Drosophila fruit flies, highlight the importance of understanding the molecular mechanisms underlying the interactions between gut microbiota and the brain. Utilizing genetic tools, axenic and gnotobiotic approaches, and transgenic flies may provide mechanistic insights into how alterations in gut-microbiota-brain interactions impact behaviors relevant to neurological disorders such as ASD.